Local pharmaceutical company Unilab has denied withholding stocks and increasing prices of Paracetamol and other medicines for flu-like symptoms.
“We refer to rumors circulating that Unilab is withholding stocks and increasing the prices of Biogesic, Bioflu, Neozep, Solmux, and Decolgen, which allegedly caused the out of stock situation in drugstores. The rumor is not true. Unilab has not increased the prices of these brands,” Unilab said in a statement.
Unilab added that the temporary out of stock situation in certain drugstores is due to the extraordinary high demand for products for fever, cough, colds, and flu in certain areas of the country.
“We continue to manufacture, and have in fact, increased the manufacturing volume of these products to serve the extraordinary demand,” it said.
“We urge everyone to refrain from relying upon and passing on false news in order not to cause public panic and anxiety. We will post, from time to time, relevant information through our social media channels,” Unilab added.